Get documents about "Studies at Saint Francis Hospital and Medical Center
Document Sample
Principal Sponsor or
Title Date Initiated
Investigator Funding Entity
The PropR Study: A Prospective Study
Comparing the Sensed R Wave in Bipolar and Aneesh Tolat, M.D. Pending Medtronic
Extended Bipolar Configurations
Retrospective Chart Review of Disease
Albert Lo, M.C. January 5, 2010 N/A
Characteristics in Multiple Sclerosis
Review of Placenta Accreta and Obstetrical December 29,
Allan Mayer, DO N/A
Complications at Saint Francis Hospital 2009
Robotic vs Laparotomy in the Staging of Early December 7, American Cancer
Allan Mayer, DO
Endometrial Cancer 2009 Society
Pharmacy Based Vaancomycin Dosing and
November 23,
Monitoring to Improve Efficient and Appropriate Jamey Dodge, R.Ph. N/A
2009
Use
Evaluation of the Effectiveness of Pharmacist
November 23,
Managed Erythropoietin Stimulating Agents Megan Keller, PharmD N/A
2009
(ESA) in the Outpatient Cancer Center
Humanitarian Use of OP-1 Implant for Multiple November 18,
Courtland Lewis, MD Stryker
Uses 2009
November 18,
Humanitarian Use of OP-1 Implant for Single Use Courtland Lewis, MD Stryker
2009
A Long Term, Randomized, Double-Blind Study of
the Safety, Tolerability and Efficacy of Aclidinium
Richard ZuWallack, November 18,
Bromide at Two Dose Levels When Administered Forest
M.D. 2009
to Patients with Moderate to Severe, Stable
Chronic Obstructive Pulmonary Disease
Health Outcomes Prospective Evaluation for November 18,
Richard Soucier, MD CVrX
Heart Failure with EF ≥ 40% (HOPE4HF) 2009
DeGennaro, Lisa November 16,
Assessing Patient Outcomes After the Addition of N/A
PharmD, BCPS 2009
a Pharmacist to the Heart Failure Clinic Team
November 5,
Thera-Band® and Body Weight Support Diana Veneri, EdD N/A
2009
Treadmill Training: The Effect on Hemiparetic
Gait in Persons Post Stroke
Improving Fetal Down Syndrome Risk
Mary Beth Janicki, November 4,
Assessment Using the First Trimester Combined N/A
M.D. 2009
Test and Second Trimester Sonography
Laparoscopic Lysis of Adhesions for Small Bowel October 23,
Ibrahim Daoud, M.D. N/A
Obstruction 2009
Using the Relaxation Response (RR) to Improve October 21,
John Levine, M.D. N/A
Functioning of Young Children with Autism 2009
The Effect of Obesity on Functional exercise
Richard ZuWallack, September 23,
Capacity, Functional Status and Health Status in N/A
M.D. 2009
COPD
Clinical Factors Determining the Care Needs of Jose Arias-Camison,
August 27, 2009 N/A
35 Week Infants MD
Coloplast Dialogue Study - An Open Label, Non-
Comparative, Multi-National Post-Market Study
Ann Navage, RN August 19, 2009 Coloplast Inc
to Document Real Life Experience on SenSura®
with Focus on Skin Condition and Quality Of Life
HZC102970: A 52-Week Efficacy and Safety
Study to Compare the Effect of Three Dosage
Strengths of Fluticasone Furoate/GW642444 Richard ZuWallack,
August 19, 2009 GlaxoSmithKline
Inhalation Power with GW642444 on the Annual M.D.
Rate of Exacerbations in Subjects with Chronic
Obstructive Pulmonary Disease (COPD)
Phaniraj Iyengar,
Stroke Center Outcome Database August 19, 2009 N/A
M.D.
Effect of Hourly Rounds on Postpartum Patient
Lee Galuska, RN Aug 14 2009 N/A
Call Light Use and Satisfaction
Soluble Fibrin and D-Dimer as a Screening Tools Courtland Lewis, MD July 28, 2009 N/A
for Venous Thromboembolism in Total Knee
Arthroplasty
Evaluation of the Efficacy of Local Infiltration Sanjay Sinha, MD July 20, 2009 N/A
Analgesia and infusion for Total Hip Arthroplasty
TYSGRIS: TYSABRI Global Observational Peter Wade, M.D. July 20, 2009 Biogen Idec, Inc
Program in Safety
NSABP B-40 A Randomized Phase III Trial of
Neoadjuvant Therapy in Patients with Palpable
and Operable Breast Cancer Evaluating the Effect
on Pathologic Complete Response (pCR) of
Adding Capecitabine or Gemcitabine to Docetaxel Susan Rabinowe, MD June 24, 2009 NSABP
when Administered Before AC with or without
Bevacizumab and Correlative Science Studies
Attempting to Identify Predictors of High
Likelihood for pCR with Each of the Regimens
CALGB 10404: A Randomized phase II Study of
Three Fludarabine/Antibody Combinations for
Adam Boruchov, M.D. May 20, 2009 CALGB
Patients with Symptomatic, Previously Untreated
Chronic Lymphocytic Leukemia
Health Promotion and Parent Engagement for
Bruce Bernstein, PhD May 5, 2009 N/A
Child Obesity Prevention
Using the Communication Assessment Tool for
Gregory Makoul, PhD April 24, 2009 N/A
Education and Quality Improvement
Prospective Assessment of Contrast Enhanced
18F-FDG Positron Emission Tomography CT
Stephen Zink, M.D. April 15, 2009 N/A
(FDG-PET-CT) in the Management of Pancreatic
Cancer
A Randomized Double-Blind, Controlled, Parallel
Group, 12-Week Treatment Study To Compare
The Efficacy and Safety of the Combination of
Indacaterol 150 ug Once Daily With Open Label Richard ZuWallack,
April 15, 2009 Novartis
Tiotropium 18 ug Once Daily Versus Open Label M.D.
Tiotropium 18 ug Once Daily In Patients With
Moderate-To-Severe Chronic Obstructive
Pulmonary Disease
S0421: Phase III Study of Docetaxel and
Atrasentan Versus Docetaxel and Placebo for Southwest
Alessia Donadio, MD April 15, 2009
Patients with Advanced Hormone Refractory Oncology Group
Prostate Cancer
Directly-Measured Activity in Patients with COPD:
Comparing Activity Counts Measured at the Richard ZuWallack,
April 8, 2009 N/A
Waist, Ankle, and Wrist with Directly-Assessed M.D.
Activity (WAW Study)
Multiple Sclerosis Genetic Susceptibility Project Albert Lo, M.C. March 25, 2009 N/A
ADC112355 A Randomized, Double-Blind,
Parallel-Group, 16 Week Study to Evaluate the
Effect of Fluticasone Propionate/Salmeterol Richard ZuWallack,
March 25, 2009 GlaxoSmithKline
Diskus 250/50 mcg BID and Placebo on Arterial M.D.
Stiffness in Subjects with Chronic Obstructive
Pulmonary Disease (COPD)
Validation Study of the Chronic Obstructive
Richard ZuWallack,
Pulmonary Disease Assessment Test (CAT) in March 19, 2009 UBC
M.D.
Rehabilitation Patients
Selective Posterior Tibial Nerve Block versus
February 18,
Popiteal Sciatic Nerve Block in Patients Having Sanjay Sinha, MD N/A
2009
Total Knee Arthroplasty
Obesity Focus Groups for Parents of Children at
Mary Stuart, M.P.H. February 9, 2009 N/A
SFHMC Pediatric Clinic
Yale University/
Variation in Recovery: Role of Gender on
January 21, National Heart,
Outcomes of Young Acute Myocardial Infarction Anita Kelsey, M.D.
2009 Lung, and Blood
(AMI) Patients- VIRGO
Institute
The Hoffman Heart and Vascular Institute December 17,
Anita Kelsey, M.D. N/A
Women's Heart Program Registry 2008
3-D Transthoracic Echocardiographic Imagining
December 10,
in Comparison to 2-D Transthoracic Anita Kelsey, M.D. N/A
2008
Echocardiographic Imaging
Prospective Study to Compare Change in
November 12,
Management Plans Before and After Presentation Joerg Rathmann, MD N/A
2008
of a Case to Tumor Board at St. Francis Hospital
Patient Perceptions of Resident Communication October 21,
Gregory Makoul, PhD N/A
Skills 2008
Tools for Improving Colorectal Cancer Screening American Cancer
Gregory Makoul, PhD October 1, 2008
Rates: Multimedia versus Print Society
Case Report: Patient with Persistent Left
September 26,
Superior Vena Cava and Absent Right Superior Peter Sandor, PA-C N/A
2008
Vena Cava
Foundation for
Testing Multimedia and Print Health Materials September 26,
Gregory Makoul, PhD Informed Medical
Across Literacy Levels 2008
Decision Making
Comparison of Neurohormonal Activation in
Patients with Acute Decompensated Heart Failure September 9,
Richard Soucier, MD N/A
with Left Ventricular Dysfunction Undergoing 2008
Ultrafiltration
Overnight Pulse Oximetry is Useful and Cost
Effective Tool to Screen for Sleep Apnea in September 5,
Richard Soucier, MD N/A
Patients Admitted with Acute Decompensated 2008
Heart Failure
Long-Term Multi-Center Evaluation of E-Poly and
Regenerex Cementless Acetabular Components: Courtland Lewis, MD August 20, 2008 Biomet
Clinical and Radiographic Outcomes
Assessing Trauma Staff Satisfaction Following
Jennifer Hale, MSN,
Implementation of a Standardized Trauma August 8, 2008 N/A
RN
Treatment Process
GOG 170-M: A Phase II Evaulation of Dasatinib
(Sprycel NSC# 732517) in the Treatment of Gynecologic
Allan Mayer, DO July 23, 2008
Persistent or Recurrent Epithelial Ovarian, Oncology Group
Fallopian Tube, or Primary Peritoneal Carcinoma
Communication Assessment Tool- Nurse Version Gregory Makoul, PhD June 19, 2008 N/A
N063D: ALTTO: Adjuvant Lapatinib and/or
Trastuzumab Treatment Optimization Study: A
North Central
Randomized, Multi-Centre, Open-Label, Phase III
Zia Rahman, MD May 19, 2008 Cancer Treatment
Study of Adjuvant Lapatinib, Trastuzumab, Their
Group
Sequence and Their Combination in Patients with
HER2/ErbB2 Positive Primary Breast Cancer
Joint Hypermobility in Children with Chronic Pain Neil Schechter, MD April 23, 2008 N/A
CSTI571A2402: A Worldwide, Observational
Registry Collecting Longitudinal Data on the
Management of Chronic Myelogenous Leukemia Syed Bilgrami, MD March 26, 2008 Novartis
(CML) Patients (The WORLD CML) Registry in
Routine Practice
A Cross-Sectional Study to Determine
Differences in Sero-Positivity and Disease Activity Kathy Dennis-
March 18, 2008 N/A
in Long Standing Rheumatoid Arthritis Patients Yawingu, MD
from Various Ethnicities
Laboratory Studies of Immune Function in
Patients with Melanoma Receiving Jonathan Sporn, MD March 18, 2008 N/A
Immunotherapy with Ipilimumab
Implementation and Evaluation of a Bright
Futures Curriculum within CORNET Continuity Grael O'Brien, MD March 13, 2008 N/A
Practices
Significance of Ethnicity in the Clinical
Kathy Dennis-
Manifestations and Progression of Early March 6, 2008 N/A
Yawingu, MD
Rheumatoid Arthritis
A Phase II, Multicenter Trial of Gemcitabine, Yale
Carboplatin and Sorafenib in Chemotherapy- February 20, University/Onyx
Alessia Donadio, MD
Naive Patients with Advanced/Metastatic Bladder 2008 Bayer
Carcinoma Pharmaceuticals
Impact of Bariatric Surgery on Untreated Ioannis Raftopoulos,
February 6, 2008 N/A
Spouses and the Home Environment MD
January 23,
CJRI Joint Registry Courtland Lewis, MD N/A
2008
E5103: A Double-Blind Phase III Trial of
Doxorubicin and Cyclophosphamide Followed by Eastern
January 23,
Paclitaxel with Bevacizumab or Placebo in Zia Rahman, MD Cooperative
2008
Patients with Lymph Node Positive and High Risk Oncology Group
Lymph Node Negative Breast Cancer
Bariatric Outcomes Longitudinal Database Ioannis Raftopoulos,
January 9, 2008 N/A
(BOLD) MD
1160.47 RE-Medy: A Phase III Randomized,
Multicenter, Double-Blind, Parallel-Group, Active
Controlled Study to Evaluate the Efficacy and
December 19, Boehringer
Safety of Oral Dabigatran Etexilate (150mg BID) Bimalin Lahiri, MD
2007 Ingelheim
Compared to Warfarin (INR 2.0-3.0) for the
Secondary Prevention of Venous
Thromboembolism
E1505: A Phase III Randomized Trial of Eastern
Adjuvant Chemotherapy with our without December 19,
Joerg Rathmann, MD Cooperative
2007
Bevacizumab for Patients with Completely Oncology Group
Resected Stage IB (>/4cm)-IIIA Non-Small Cell
Lung Cancer (NSCLC)
Quality Improvement Activities at Burgdorf December 16,
Bruce Gould, MD N/A
Health Center: Chronic Pain 2007
ESP Registry: Evaluation of Simplified Predictors December 6,
Richard Soucier, MD N/A
of Advance Heart Failure 2007
NSABP B-42: A Clincial Trial to Determine the
Efficacy of Five Years of Letrozole Compared to
Placebo in Patients Completing Five Years of
National Surgical
Hormonal Therapy Consisting of an Aromatase November 21,
Susan Rabinowe, MD Adjuvant Breast
Inhibitor (AI) or Tamoxifen Followed by an AI in 2007
and Bowel Project
Prolonging Disease-Free Survival in
Postmenopausal Women with Hormone Receptor
Positive Breast Cancer
Physical Activity in COPD Exacerbation (PACE) Richard ZuWallack, November 13,
N/A
Study MD 2007
October 24,
ReCKord Cyberknife Registry Joseph Colasanto, MD N/A
2007
GOG 235: A Prospective, Longitudinal Study of
YKL-40 In Patients With FIGO Stage III or IV
October 24, Gynecologic
Invasive Epithelial Ovarian, Primary Peritoneal, Allan Mayer, DO
2007 Oncology Group
or Fallopian Tube Cancer Undergoing Primary
Chemotherapy
Ioannis Raftopoulos, October 24,
Bartiatric Center Research Registry N/A
MD 2007
S0307: Phase III Trial of Bisphosphonates as September 26,
Zia Rahman, MD SWOG
Adjuvant Therapy for Primary Breast Cancer 2007
GOG 0224: A Randomized, Controlled Phase II
Evaluation of Megestrol (Megace) in Different
Dose and Sequence in the Treatment of September 26, Gynecologic
Beth Nelson, MD
Endometrial Intraepithelial Neoplasia (EIN) From 2007 Oncology Group
a Referred Cohort of Atypical Endometrial
Hyperplasia (AEH) or EIN
CA184-045: A Multicenter Treatment Protocol
for Compassionate Use of Ipilimumab (BMS- September 26, Bristol-Myers-
Jonathan Sporn, MD
734016) Monotherapy in Subjects with 2007 Squibb
Unresectable Stage III or Stage IV Melanoma
Quality Improvement Activities at the Burgdorf
Bruce Gould, MD August 16, 2007 N/A
Health Center: Arterial Hypertension
205.368: A Randomized, Double-Blind, Placebo-
Controlled Two Year Trial to Examine the
Richard ZuWallack, Boehringer
Changes in Exercise Endurance and COPD in April 24, 2007
MD Ingelheim
Patients Treated with Tiotropium (Spiriva
Handihaler) 18ug Once Daily (EXACTT Trial)
National
Environment, Gene and Testicular Cancer Risk February 21,
Zia Rahman, MD Institutes of
Study 2007
Health
National
February 21,
Meningioma: Risk Factors and Quality of Life Zia Rahman, MD Institutes of
2007
Health
Department of
Assessing Depression and Preventing Suicide in January 24,
Aric Schichor, MD Mental Health and
Adolescents (ADAPSA) 2007
Addition Services
Lontigutindal Study of Breathlessness in Patients Richard ZuWallack, December 20, Psychological
with Lung Disease MD 2006 Applications
Quality Improvement and Quality Assurance October 23,
Bruce Gould, MD N/A
Activity at Burgdorf Health Center: Asthma 2006
September 27, National Hansen's
Use of Clofazimine in Patients with Leprosy Robert Lyons, MD
2006 Disease Programs
E2805: A Randomized, Double-Blind Phase III
Eastern
Trial of Adjuvant Sunitinib versus Sorafenib September 27,
Alessia Donadio, MD Cooperative
versus Placebo in Patients with Resected Renal 2006
Oncology Group
Cell Carcinoma
Program for the Assessment of Clinical Cancer
Eastern
Tests (PACCT-1): Trial Assigning Individualized
Zia Rahman, MD May 24, 2006 Cooperative
Options for Treatment: The TAILORx Trial
Oncology Group
(Version date April 7, 2006)
Breaking the Cycle of Behavioral Health Problems
December 21, National Institute
and Crime (Mothers Overcoming and Managing Bruce Bernstein, PhD
2005 of Justice
Stress - M.O.M.S.)
Quality Improvement Monitor Activity at Burgdorf November 28,
Bruce Gould, MD N/A
Health Center. Adult Onset Diabetes 2005
SCO104960 - A Multicentre 3 Year Longitudinal
Prospective Study to Identify Novel Endpoints
and Compare These With Forced Expiratory Richard ZuWallack, November 23,
GlaxoSmithKline
Volume in 1 Second (FEV1) For Their Ability To MD 2005
Measure and Predict COPD Severity and its
Progression Over Time
Effect of Depression on Diabetic Control and Devra Khanh Dang, October 25,
N/A
Medication Adherence PharmD 2005
GOG #218: A Phase III Trial of Carboplatin &
Paclitaxel plus Placebo versus Carboplatin &
Paclitaxel plus Concurrent Bevacizumab followed
by Placebo, versus Carboplatin & Paclitaxel plus October 26, Gynecologic
Beth Nelson, MD
Concurrent & Extended Bevacizumab in Woman 2005 Oncology Group
with Newly Diagnosed, Previously Untreated,
Stage III or IV Epithelial Ovarian or Primary
Peritoneal Cancer
Prevention of Post-ERCP Pancreatitis with Non-
Michael Butensky, MD May 25, 2005 AXCAN Pharma
Enterocoated Pancreatic Enzymes
GOG#212: A Randomized Phase III Trial of
Maintenance Chemotherapy Comparing 12
Monthly Cycles of Single Agent Paclitaxel or
Xyotax (CT-2103) (IND#70,177), Versus No
Gynecologic
Treatment Until Documented Relapse in Women Allan Mayer, DO April 27, 2005
Oncology Group
with Advanced Ovarian or Primary Peritoneal
Cancer Who Achieve a Complete Clinical
Response to Primary Platinum/Taxane
Chemotherapy
NSABP-38: A Phase III, Adjuvant Trial
Comparing Three Chemotherapy Regimens In
Women with Node-Positive Breast Cancer:
National Surgical
Docetaxel/Doxorubicin/Cyclophosphamide (TAC);
Susan Rabinowe, MD April 27, 2005 Adjuvant Breast
Dose-Dense (DD) Doxorubicin/Cyclophosphamide
and Bowel Project
Followed by DD Paclitaxel (DD AC-P); DD AC
Followed by DD Paclitaxel plus Gemcitabine (DD
AC-PG)
E4101:A Randomized Phase II Trial of
Eastern
Combination Anastrozole plus ZD1839 and of January 19,
Combination Fulvestrant plus ZD1839 in the Zia Rahman, MD Cooperative
2005
Oncology Group
Treatment of Postmenopausal Women with
Hormone Receptor-Positive Metastatic Breast
Cancer
GOG#188: A Phase II Study of Faslodex in October 20, Gynecologic
Allan Mayer, DO
Recurrent/Metastatic Endometrial Cancer 2004 Oncology Group
U2963n: The National Lymphocare Study: An
Genentech, Inc.
Observational Study of Treatment, Outcomes, September 21,
Jonathan Sporn, MD and Biogen Idec,
and Prognosis in Patients with Follicular Non- 2004
Inc.
Hodgkin’s Lymphoma
E2103: A Phase II Trial of Trastuzumab plus
Eastern
weekly Ixabepilone (BMS-247550) and
Zia Rahman, MD August 25, 2003 Cooperative
Carboplatin in Patients with HER2/Neu-Positive
Oncology Group
Metastatic Breast Cancer
Prevalence of Proteinuria and Pregnancy
Carolyn Zelop, MD August 5, 2004 N/A
Outcomes in Gestational Diabetes
N0147: A Randomized Phase III Trial of
Irinotecan (CPT-11) and/or Oxaliplatin (OXAL) North Central
plus 5-Fluoroouracil (5-FU)/Leucovorin (CF) after Jonathan Sporn, MD June 23, 2004 Cancer Treatment
Curative Resection for Patients with Stage III Group
Colon Cancer
JOSTENT GraftMaster Humanitarian Use Device Daniel Diver, MD June 23, 2004 Eminent Research
National Cancer
Epidemiologic Study of Uterus Cancer Zia Rahman, MD April 14, 2004
Institute
Case Control Study of Pancreas Cancer Etiology National Cancer
Zia Rahman, MD April 14, 2004
Factors Institute
MA.27: A Randomized Phase III Trial of
Exemestane Versus Anastrozole With or Without February 18, Cancer Trials
Zia Rahman, MD
Celecoxib in Postmenopausal Women with 2004 Support Unit
Receptor Positive Primary Breast Cancer
Robert Wood
Reducing Tobacco Use and Risky Drinking in February 11, Johnson Medical
Keith vom Eigen, MD
Underserved Populations 2004 Research
Foundation
Follow-Up to E2993: Phase III Randomized Trial
of Autologous and Allogeneic Bone Marrow Eastern
Transplantation vs. Intensive Conventional Zia Rahman, MD June 23, 1993 Cooperative
Chemotherapy in Acute Lymphoblastic Leukemia Oncology Group
in 1st Remission
GOG#199: Prospective Study of Risk-Reducing
Salpingo-Oophorectomy and Longitudinal CA-125 Gynecologic
Allan Mayer, DO August 20, 2003
Screening Among Women at Increased Genetic Oncology Group
Risk of Ovarian Cancer
American Cancer
The National Quality of Life Study Zia Rahman, MD April 23, 2003
Society
NSABP B-35: A Clinical Trial Comparing
National Surgical
Anastrazole with Tamoxifen in Postmenopausal
Susan Rabinowe, MD April 23, 2003 Adjuvant Breast
Patients with Ductal Carcinoma In Situ (DCIS)
and Bowel Project
Undergoing Lumpectomy with Radiation Therapy
C40101: Cyclophosphamide and Doxorubicin (4
vs 6 cycles) Vs. Paclitaxel (12 wks vs 18 wks) as
Cancer Trials
Adjuvant Therapy for Women with Node- Zia Rahman, MD April 23, 2003
Support Unit
Negative Breast Cancer: a 2x2 Factorial Phase III
Randomized Study
Dongahue
Hospitals and Churches: Partnership to Improve
Judith Fifield, PhD, RN July 16, 2002 Research
Health
Foundation
Gluthathione-S-Transferase Polymorphisms,
George Barrows, MD June 18, 2002 N/A
Race, and Survival from Cancer
National Surgical
NSABP P-2: Study of tamoxifen and Raloxifene
Susan Rabinowe, MD May 22, 2002 Adjuvant Breast
(STAR) for the Prevention of Breast Cancer
and Bowel Project
National Surgical
January 15,
Follow-up of single patient from NSABP B-32 Susan Rabinowe, MD Adjuvant Breast
2002
and Bowel Project
Dongahue
Gambling and Brief Interventions Keith vom Eigen, MD October 1, 2001 Medical Research
Foundation
Patrick &
Exploration of the Effect of Nausea, Self-efficacy, Catherine Weldon
Elizabeth Anderson,
and Health Care Relationships on Medication August 22, 2001 Donaghue
PhD
Adherence in AIDS Patients Medical Research
Foundation
A Three-Arm Randomized Trial to Compare National Surgical
Adjuvant Adriamycin and Cytoxan Followed by Susan Rabinowe, MD April 21, 1999 Adjuvant Breast
Taxotere (AC-T); Adriamycin and Taxotere (AT); and Bowel Project
and Adriamycin, Taxotere and Cytoxan (ATC) in
Breast Cancer Patients with Positive Axillary
Lymph Nodes
A Trial to Evaluate the Worth of Tumor
Biomarkers Obtained by Fine Needle Aspiration
National Surgical
or Core Biopsy in Predicting Response to
Susan Rabinowe, MD May 21, 1997 Adjuvant Breast
Preoperative Chemotherapy and Long-term
and Bowel Project
Outcome in Patients with Operable Breast Cancer
Who are Participating in NSABP Protocol B-27
A Trial to Evaluate the Worth of Serum ErbB-2
Extracellular Domain and Serum ErbB-2
National Surgical
Antibodies in Predicting Response to Preoperative
Susan Rabinowe, MD May 21, 1997 Adjuvant Breast
Chemotherapy and Long-term Outcome in
and Bowel Project
Patients with Operable Breast Cancer Who are
Participating in NSABP Protocol B-27
A Randomized Trial Comparing Preoperative
Doxorubicin (Adriamycin), Cyclophosphamide
National Surgical
(AC) to Preoperative AC Followed by Preoperative October 23,
Susan Rabinowe, MD Adjuvant Breast
Docetaxel (Taxotere) and to Preoperative AC 1996
and Bowel Project
Followed by Postoperative Docetaxel in Patients
with Operable Carcinoma of the Breast
BCIRG 006 (TAX GMA 302): Multicenter Phase
III Randomized Trial Comparing Doxorubicin and
Cyclophosphamide Followed by Docetaxel (AC-T) Aventis
with Doxorubicin and Cyclophosphamide Pharmaceuticals,
Followed by Docetaxel and Trastuzumab (AC-TH) Inc./Breast
Zia Rahman, MD April 25, 2001
and with Docetaxel, Platinum Salt and Cancer
Trastuzumab (TCH) in the Treatment of Node International
Positive and High Risk Node Negative Adjuvant Research Group
Patients with Operable Breast Cancer Containing
the HER2/neu Alteration
GOG#182: A Phase III Randomized Trial of
Paclitaxel and Carboplatin Versus Triplet or
February 21, Gynecologic
Sequential Doublet Combinations in Patients with Allan Mayer, DO
2001 Oncology Group
Epithelial Ovarian or Primary Peritoneal
Carcinoma
Thyde Dumont- November 6,
A Qualitative Analysis of the Ethno-cultural N/A
Perceptions of Effective Parenting and Mathieu, MD 2000
Appropriate Anticipatory Guidance
E1199: A Phase III Study of Doxorubicin-
Cyclophosphamide Therapy Followed by Eastern
Paclitaxel or Docetaxel Given Weekly or Every 3 Zia Rahman, MD June 28, 2000 Cooperative
Weeks in Patients with Axillary Node-Positive Oncology Group
Breast Cancer
E7293: A Phase III Prospective Randomized Eastern
Trial Comparing Laparoscopic-Assisted Colectomy Steven Brown, MD March 24, 1999 Cooperative
Versus Open Colectomy for Colon Cancer Oncology Group
S9313: Phase III Comparison of Adjuvant
Chemotherapy with High-Dose
Cyclophosphamide plus Doxorubicin (AC) versus Eastern
Sequential Doxorubicin Followed by Zia Rahman, MD June 8, 1994 Cooperative
Cyclophosphamide (A->C) in High-Risk Breast Oncology Group
Cancer Patients with 0-3 Positive nodes
(Intergroup)
S9005: Double Blind Randomized Trial of the Eastern
December 22,
Antiprogestational Agent Mifepristone in the Zia Rahman, MD Cooperative
1993
Treatment of Unresectable Meningioma Phase III Oncology Group
E4494: Phase III Trial of CHOP versus CHOP and
Chimeric Anti CD-20 Monoclonal Antibody (IDEC- Eastern
C2B8) in Older Patients with Diffuse Mixed, Zia Rahman, MD April 8, 1998 Cooperative
Diffuse Large Cell and Immunoblastic Large Cell Oncology Group
Histology Non-Hodgkin’s Lymphoma
E4188: Phase III Study of CAF plus Concurrent
Eastern
or Delayed Tamoxifen versus Tamoxifen Alone in
Zia Rahman, MD July 21, 1989 Cooperative
Postmenopausal Patients with Positve Nodes and
Oncology Group
Receptors- Intergroup
E3487: Phase III Comparison of CHOP versus M-
Eastern
Bacod versus ProMACE CytaBOM versus MACOP- December 16,
Zia Rahman, MD Cooperative
B in Patients with Intermediate or High-Grade 1988
Oncology Group
Non-Hodgkin’s Lymphoma
E2389: Phase III Evaluation of Post-Operative Eastern
January 29,
Radiation in Low-Grade Astocytomas and Zia Rahman, MD Cooperative
1992
Oligodendrogliomas- Intergroup Oncology Group
E2188: Phase III Comparison of Adjuvant
Chemotherapy with or without Endocrine Eastern
Therapy in High-Risk, Node-Negative Breast Zia Rahman, MD July 21, 1988 Cooperative
Cancer Patients, and a Natural History Follow-Up Oncology Group
Study in Low-Risk, Node-Negative Patients
C9344: Doxorubicin Dose Escalation, with or
Eastern
without Taxol, as part of the CA Adjuvant October 14,
Zia Rahman, MD Cooperative
Chemotherapy Regimen for Node-Positive Breast 1994
Oncology Group
Cancer: A Phase III Intergroup Study
DMS 9801: A Prospective Study of Adjuvant
Radiation Therapy After Resection of Borderline Bruce Kaplan, MD July 1, 1998 N/A
and Malignant Phyllodes Tumors
The Roll of Epstein-Barr Virus in the Etiology of National Cancer
Zia Rahman, MD May 15, 1998
Hodgkin's Disease Institute
Case Control Study of Ovarian Cancer Hormonal National Cancer
Zia Rahman, MD May 15, 1998
Etiology Institute
Race Differences in the Screening Mammography National Cancer
Zia Rahman, MD July 31, 1996
Process Institute
Department of
The Genetic Epidemiology of Breast Carcinoma in Defense Breast
Zia Rahman, MD April 10, 1996
Situ Cancer Research
Program
